Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study

Abstract Background Transthyretin cardiac cardiomyopathy (ATTR-CM) is a rare but life-threatening disease. Tafamidis is an effective treatment for patients with ATTR-CM, however its long-term effects on cardiac remodeling and cardiac amyloid deposition are unknown. This study aimed to used cardiac m...

Повний опис

Бібліографічні деталі

Автори:	Cheng-Hsuan Tsai, Chi-Chao Chao, Sung-Tsang Hsieh, An-Li Yu, Yuan-Kun (Aden) Wu, Mei-Fang Cheng, Ming-Jen Lee, Chia-Hung Chou, Chia-Tung Shun, Hsueh-Wen Hsueh, Jimmy Jyh-Ming Juang, Ping-Huei Tseng, Mao-Yuan Su, Yen-Hung Lin
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2023-09-01
Серія:	Orphanet Journal of Rare Diseases
Предмети:	Cardiac magnetic resonance Extracellular volume Hereditary transthyretin amyloidosis Tafamidis
Онлайн доступ:	https://doi.org/10.1186/s13023-023-02824-0
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!